Gregory Henkel
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$5.7MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $5.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 25, 2021 | DoD | SBIR Phase II Evaluation of ARN-75039 for dual efficacy against both parenteral and aerosolized Lassa virus infection in a guinea pig model. | $269K | ARISAN THERAPEUTICS INC |
| Feb 6, 2020 | DoD | SBIR Phase I Development of Small Molecule Therapeutics for Emerging Viral Agents | $96K | ARISAN THERAPEUTICS INC |
| May 1, 2019 | NIH | SBIR Phase II Development of a Highly Sensitive Quantitative Rapid Digital LSPR Diagnostic for Acute Dengue and Zika Virus Infection | $2.0M | ARISAN THERAPEUTICS INC |
| Aug 1, 2016 | NIH | STTR Phase I Ultrasensitive Point-of-Care Diagnostics of Viral Biomarkers and Infectious Diseases | $300K | ARISAN THERAPEUTICS INC |
| Apr 1, 2016 | NIH | SBIR Phase II Arenavirus Antiviral Lead Optimization | $3.0M | ARISAN THERAPEUTICS INC |
Peer ranks
Federal funding#214
Awards as PI#417
Patents#273
Companies
- ARISAN THERAPEUTICS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.